Zobrazeno 11 - 20
of 92
pro vyhledávání: '"Li-Na He"'
Autor:
Linfeng Luo, Anlin Li, Sha Fu, Wei Du, Li-Na He, Xuanye Zhang, Yixing Wang, Yixin Zhou, Yang Yunpeng, Zhang Li, Shaodong Hong
Publikováno v:
Immunologic Research. 71:213-228
Non-small-cell lung cancer (NSCLC) remains the major cause of cancer-related death. Immune checkpoint inhibition has become the cornerstone treatment for NSCLC. Cuproptosis is a newly identified form of cell death relying on mitochondrial respiration
Autor:
Li-Na He, Si Chen, Qi Yang, Zheng Wu, Zheng-Kai Lao, Chang-Fei Tang, Jiao-Jiao Song, Xian-Dong Liu, Jiangteng Lu, Xiao-Hong Xu, Jin-Jin Chen, Tian-Le Xu, Suya Sun, Nan-Jie Xu
Publikováno v:
Proceedings of the National Academy of Sciences. 120
Social behavior starts with dynamic approach prior to the final consummation. The flexible processes ensure mutual feedback across social brains to transmit signals. However, how the brain responds to the initial social stimuli precisely to elicit ti
Autor:
WEI CHEN1,2, LI‑NA HE3 urologyly@163.com, YONG LIANG2, XIANG ZENG2, CUI‑PING WU1, MING-QIANG SU2, YANG CHENG2, JIAN‑HUI LIU2
Publikováno v:
Molecular Medicine Reports. Dec2020, Vol. 22 Issue 6, p5209-5218. 10p.
Autor:
Tao Chen, Li-na He, Chen Chen, Yixin Zhou, Zuan Lin, Haifeng Li, Shaodong Hong, Xuanye Zhang, Li Zhang, Yuhong Wang
Publikováno v:
Cancer Immunology, Immunotherapy. 71:1247-1255
The use of anti-programmed cell death-1 (PD-1) antibodies in treating malignancies is increasing; however, most registered clinical trials on anti-PD-1 antibodies exclude patients infected with hepatitis B virus (HBV). This retrospective study aimed
Publikováno v:
IEEE Transactions on Antennas and Propagation. 69:5356-5364
For spaceborne transmitting systems, strip antennas provide a new scheme in boosting the radiation efficiency due to their availability in generating larger current moments. In this article, we investigate the theory of a very-low-frequency (VLF: 3
Publikováno v:
Hemoglobin. 46(5)
Thalassemia is one of southern China's most common inherited disorders. Little is known about the genotypes of thalassemia in children in Jiangxi Province, the People's Republic of China (PRC). Two thousand, nine hundred and fifty-two children with s
Autor:
Yixin Zhou, Chen Chen, Xuanye Zhang, Hongyun Zhao, Zuan Lin, Wenfeng Fang, Yan Huang, Wei Du, Tao Chen, Shaodong Hong, Li-na He, Yunpeng Yang, Sha Fu, Qiaozhen Hu, Li Zhang, Haifeng Li, Yongluo Jiang
Publikováno v:
Lung Cancer. 158:1-8
Systemic inflammation plays an important role in carcinogenesis and is associated with overall survival in patients with different cancer types, including those treated with immune checkpoint blockade (ICB). Serum Amyloid A (SAA) is an acute-phase pr
Autor:
Chen Chen, Bei Zhang, Yixin Zhou, Hui Yu, Shaodong Hong, Xuanye Zhang, Ping Chen, Xiuyu Cai, Li-na He
Publikováno v:
Cancer Immunology, Immunotherapy. 71:637-644
Programmed cell death-ligand 1 inhibitors plus chemotherapy (PD-L1 + Chemo) have achieved substantial progress in extensive-stage small-cell lung cancer (ES-SCLC). However, evidence about programmed cell death 1 inhibitors plus chemotherapy (PD-1 + C
Autor:
Zuan Lin, Teresa Moran, Shaodong Hong, Dan Tian, Yixin Zhou, Tao Chen, Li-na He, Sha Fu, Yuhong Wang, Xuanye Zhang, Ross A. Soo, In-Jae Oh, Haifeng Li, Satoshi Watanabe, Li Zhang, Francesco Passiglia, Ernest Nadal, Yue Chen, Chen Chen, Alessandro Russo
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Transl Lung Cancer Res
Translational Lung Cancer Research
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Universidad de Barcelona
Transl Lung Cancer Res
Translational Lung Cancer Research
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background: The aim of this study was to evaluate the safety and survival outcomes of anti-programmed cell death (PD)-1/programmed cell death-ligand 1 (PD-L1) monotherapy in patients with advanced nonsmall cell lung cancer (NSCLC) and different hepat